Skip to main content

Table 2 Exosomes extracted from biofluids as diagnostic and prognostic biomarkers for GC

From: Exosomes in gastric cancer: roles, mechanisms, and applications

Cargo type

Exosomal cargo

Biofluids

Extraction method

Identification method

Method

Clinical value in GC

Reference

Protein

BARHL2

Gastric juice

Commercial kit

Not shown

qRT-PCR

BARHL2 methylation yielded an AUC of 0.923 with 90% sensitivity and 100% specificity

[69]

GKN1

Serum

Commercial kit

TEM

ELISA

Discriminate GC patients from healthy individuals (AUC = 1.00), patients with hepatocellular (AUC = 1.00) and colorectal carcinomas (AUC = 0.98)

[47]

TGF-β1

Plasma

Differential centrifugation

Western blot, immuno-EM and NTA

ELISA

Associated with lymph node metastasis

[43]

TRIM3

Serum

Commercial kit

TEM and NTA

ELISA, western blot

Downregulated in GC and may serve as a biomarker for GC diagnosis

[52]

miRNA

miR-423-5p

Serum

Commercial kit

TEM, NTA and western blot

qRT-PCR

Higher diagnostic efficiency than CEA and CA-199;

indicator for poor prognosis

[54]

miR-451

Serum

Commercial kit

Not shown

qRT-PCR

indicate poor prognosis of GC patients

[58]

miR-217

Plasma

Differential centrifugation

Not shown

qRT-PCR

Higher expression in GC patients

[71]

miR-23b

Plasma

Ultracentrifugation

TEM

miRNA microarray,

qRT-PCR

Predicts the recurrence and prognosis of GC patients in each tumor stage

[74]

miR-19b-3p and miR-106a-5p

Serum

Commercial kit

TEM and western blot

qRT-PCR

Related to GC lymphatic metastasis and TNM stage;

more accurate than AFP and CA19–9 for GC diagnosis

[70]

miR10b-5p, miR195-5p, miR20a-3p, and miR296-5p

Serum

Commercial kit

Not shown

miRNA microarray, qRT-PCR

Elevated expression in GC patients

[24]

miR-424-5p and miR-590-3p

Serum

Commercial kit

TEM, NTA and western blot

miRNA profiling,qRT-PCR

Effective biomarker for diagnosing the stage of GC progression

[72]

miR-21 and miR-1225-5p

Peritoneal lavage fluid

Differential centrifugation

Not shown

miRNA microarray,

qRT-PCR

Biomarker for the prediction of peritoneal dissemination

[73]

lncRNA

lncUEGC1

Plasma

Serial centrifugation and discontinuous

iodixanol gradient

TEM, NTA and western blot

RNA sequencing,

qPCR

Potential early GC biomarker with higher diagnostic accuracy than CEA

[66]

HOTTIP

Serum

Ultracentrifugation

Not shown

qRT-PCR

Higher diagnostic capability than CEA, CA 19–9 and CA72–4;

correlated with poor overall survival

[65]

ZFAS1

Serum

Commercial kit

TEM, NTA and western blot

qRT-PCR

Higher levels in GC patients;

associated with lymph node metastasis and TNM stage

[64]

LINC00152

Plasma

Commercial kit

TEM

qRT-PCR

Higher levels in GC patients

[10]

circRNA

circ-KIAA1244

Plasma

Commercial kit

Not shown

circRNA microarray,

qRT-PCR

Potential diagnostic and prognostic biomarker for GC

[67]